| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.851 | 0.002 | 0.851 | Histamine H1 receptor antagonist | 0.535 0.004 DBMET00377 0.306 0.006 DBMET02787 | ||
| 0.672 | 0.004 | 0.672 | Antihistaminic | 0.406 0.006 DBMET00377 0.197 0.021 DBMET02787 | ||
| 0.668 | 0.004 | 0.668 | Histamine antagonist | 0.403 0.005 DBMET00377 0.185 0.022 DBMET02787 | ||
| 0.537 | 0.039 | 0.537 | Analgesic | 0.385 0.091 DBMET00377 0.38 0.093 DBMET02787 | ||
| 0.45 | 0.016 | 0.494 | Anticonvulsant | 0.494 0.012 DBMET00377 0.261 0.053 DBMET02787 | DBMET00377 | |
| 0.432 | 0.039 | 0.736 | 5 Hydroxytryptamine release stimulant | 0.736 0.005 DBMET00377 0.73 0.005 DBMET02787 0.649 0.01 DBMET02792 | DBMET00377 | |
| 0.403 | 0.064 | 0.424 | Antiobesity | 0.358 0.083 DBMET00377 0.317 0.105 DBMET02787 0.424 0.057 DBMET02792 | DBMET02792 | |
| 0.32 | 0.031 | 0.358 | Platelet aggregation inhibitor | 0.358 0.024 DBMET00377 0.266 0.045 DBMET02787 0.207 0.076 DBMET02792 | DBMET00377 | |
| 0.289 | 0.016 | 0.289 | Antipruritic | 0.237 0.029 DBMET00377 0.211 0.042 DBMET02787 0.175 0.069 DBMET02792 | ||
| 0.31 | 0.066 | 0.367 | Spasmolytic | 0.24 0.096 DBMET00377 0.205 0.115 DBMET02787 0.367 0.048 DBMET02792 | DBMET02792 | |
| 0.248 | 0.029 | 0.248 | Cholinergic | 0.143 0.082 DBMET00377 0.178 0.057 DBMET02787 | ||
| 0.223 | 0.006 | 0.223 | Pregnane X receptor agonist | 0.208 0.009 DBMET00377 0.195 0.012 DBMET02787 | ||
| 0.318 | 0.104 | 0.459 | GABA C receptor rho-3 antagonist | 0.459 0.038 DBMET00377 0.427 0.05 DBMET02787 | DBMET00377 | |
| 0.245 | 0.034 | 0.245 | Amyloid beta precursor protein antagonist | |||
| 0.201 | 0.014 | 0.201 | Acetylcholine agonist | 0.089 0.056 DBMET00377 | ||
| 0.217 | 0.035 | 0.217 | Acetylcholine M1 receptor antagonist | 0.209 0.038 DBMET00377 0.142 0.083 DBMET02787 | ||
| 0.188 | 0.007 | 0.188 | Acetylcholine muscarinic agonist | |||
| 0.21 | 0.031 | 0.21 | Insulin secretagoues | 0.198 0.037 DBMET02792 | ||
| 0.274 | 0.111 | 0.37 | Vasodilator, peripheral | 0.37 0.066 DBMET00377 0.31 0.092 DBMET02787 0.336 0.08 DBMET02792 | DBMET00377 | |
| 0.185 | 0.023 | 0.227 | MAP3K9 inhibitor | 0.227 0.008 DBMET00377 0.212 0.011 DBMET02787 0.145 0.068 DBMET02792 | DBMET00377 | |
| 0.181 | 0.02 | 0.46 | 5 Hydroxytryptamine 2C antagonist | 0.46 0.005 DBMET00377 0.219 0.015 DBMET02787 | DBMET00377 | |
| 0.322 | 0.171 | 0.412 | Caspase 9 stimulant | 0.412 0.104 DBMET00377 0.361 0.137 DBMET02787 0.396 0.114 DBMET02792 | DBMET00377 | |
| 0.179 | 0.031 | 0.43 | 5 Hydroxytryptamine 2B antagonist | 0.43 0.007 DBMET00377 0.238 0.02 DBMET02787 | DBMET00377 | |
| 0.212 | 0.066 | 0.304 | Neurotrophic factor enhancer | 0.259 0.034 DBMET00377 0.289 0.021 DBMET02787 0.304 0.017 DBMET02792 | DBMET02792 | |
| 0.151 | 0.007 | 0.151 | Acetylcholine M1 receptor agonist | |||
| 0.158 | 0.015 | 0.158 | Acetylcholine M3 receptor agonist | |||
| 0.169 | 0.036 | 0.195 | Platelet activating factor antagonist | 0.195 0.028 DBMET00377 0.116 0.066 DBMET02787 | DBMET00377 | |
| 0.135 | 0.005 | 0.165 | Farnesyltransferase inhibitor | 0.165 0.004 DBMET00377 0.122 0.005 DBMET02787 0.053 0.024 DBMET02792 | DBMET00377 | |
| 0.268 | 0.142 | 0.464 | Histamine release inhibitor | 0.294 0.127 DBMET00377 0.264 0.145 DBMET02787 0.464 0.043 DBMET02792 | DBMET02792 | |
| 0.199 | 0.075 | 0.199 | Anesthetic general | 0.175 0.09 DBMET00377 0.136 0.13 DBMET02787 0.136 0.13 DBMET02792 | ||
| 0.135 | 0.013 | 0.195 | Acetylcholine M4 receptor antagonist | 0.195 0.006 DBMET00377 0.092 0.035 DBMET02787 | DBMET00377 | |
| 0.216 | 0.096 | 0.404 | Tumour necrosis factor alpha release inhibitor | 0.249 0.076 DBMET00377 0.192 0.116 DBMET02787 0.404 0.026 DBMET02792 | DBMET02792 | |
| 0.121 | 0.01 | 0.121 | Acetylcholine M5 receptor agonist | |||
| 0.147 | 0.036 | 0.189 | Interleukin 8 antagonist | 0.189 0.016 DBMET00377 0.165 0.026 DBMET02787 | DBMET00377 | |
| 0.148 | 0.039 | 0.375 | Alpha 2b adrenoreceptor antagonist | 0.375 0.005 DBMET00377 0.248 0.015 DBMET02787 | DBMET00377 | |
| 0.127 | 0.018 | 0.299 | Dopamine D1 antagonist | 0.238 0.008 DBMET00377 0.299 0.006 DBMET02787 | DBMET02787 | |
| 0.129 | 0.023 | 0.137 | Lanosterol 14 alpha demethylase inhibitor | 0.137 0.017 DBMET00377 0.099 0.057 DBMET02787 | DBMET00377 | |
| 0.119 | 0.016 | 0.128 | Benzodiazepine agonist | 0.128 0.013 DBMET00377 | DBMET00377 | |
| 0.162 | 0.059 | 0.263 | GABA C receptor rho-2 antagonist | 0.263 0.009 DBMET00377 0.25 0.012 DBMET02787 | DBMET00377 | |
| 0.121 | 0.02 | 0.121 | Histamine H2 receptor antagonist | |||
| 0.146 | 0.046 | 0.391 | 5 Hydroxytryptamine 2 antagonist | 0.391 0.01 DBMET00377 0.194 0.032 DBMET02787 | DBMET00377 | |
| 0.228 | 0.128 | 0.413 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.413 0.019 DBMET00377 0.372 0.028 DBMET02787 | DBMET00377 | |
| 0.115 | 0.018 | 0.115 | Calcium channel L-type blocker | |||
| 0.2 | 0.104 | 0.312 | MAP-kinase-activated kinase 5 inhibitor | 0.312 0.024 DBMET00377 0.276 0.044 DBMET02787 | DBMET00377 | |
| 0.194 | 0.098 | 0.472 | Cyclic AMP phosphodiesterase inhibitor | 0.319 0.035 DBMET00377 0.274 0.053 DBMET02787 0.472 0.009 DBMET02792 | DBMET02792 | |
| 0.1 | 0.004 | 0.1 | Acetylcholine M4 receptor agonist | |||
| 0.118 | 0.024 | 0.314 | 5 Hydroxytryptamine 1F antagonist | 0.314 0.005 DBMET00377 0.161 0.015 DBMET02787 | DBMET00377 | |
| 0.234 | 0.14 | 0.624 | Antithrombotic | 0.228 0.146 DBMET00377 0.193 0.186 DBMET02787 0.624 0.014 DBMET02792 | DBMET02792 | |
| 0.106 | 0.014 | 0.178 | 5 Hydroxytryptamine 5A antagonist | 0.178 0.005 DBMET00377 0.103 0.015 DBMET02787 | DBMET00377 | |
| 0.1 | 0.009 | 0.1 | Potassium channel intermediate-conductance Ca-activated blocker | 0.056 0.052 DBMET00377 | ||
| 0.116 | 0.026 | 0.126 | Bromodomain-containing protein 2 inhibitor | 0.126 0.019 DBMET00377 0.086 0.064 DBMET02787 | DBMET00377 | |
| 0.104 | 0.014 | 0.19 | 5 Hydroxytryptamine 5 antagonist | 0.19 0.005 DBMET00377 0.099 0.015 DBMET02787 | DBMET00377 | |
| 0.203 | 0.114 | 0.203 | Neuropeptide Y2 antagonist | 0.189 0.14 DBMET00377 | ||
| 0.285 | 0.197 | 0.285 | MAP kinase 1 inhibitor | |||
| 0.146 | 0.061 | 0.195 | Interleukin 1 antagonist | 0.195 0.035 DBMET00377 0.123 0.085 DBMET02787 | DBMET00377 | |
| 0.105 | 0.022 | 0.105 | Amidase inhibitor | |||
| 0.088 | 0.01 | 0.088 | Acetylcholine M2 receptor agonist | |||
| 0.128 | 0.05 | 0.165 | GABA receptor agonist | 0.165 0.029 DBMET00377 0.096 0.082 DBMET02787 | DBMET00377 | |
| 0.102 | 0.027 | 0.217 | Dopamine agonist | 0.191 0.01 DBMET00377 0.217 0.009 DBMET02787 0.06 0.052 DBMET02792 | DBMET02787 | |
| 0.115 | 0.04 | 0.135 | Antineoplastic alkaloid | 0.125 0.035 DBMET00377 0.135 0.032 DBMET02787 | DBMET02787 | |
| 0.12 | 0.048 | 0.132 | Acetylcholine release stimulant | 0.132 0.032 DBMET00377 | DBMET00377 | |
| 0.172 | 0.102 | 0.361 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.361 0.021 DBMET00377 0.34 0.025 DBMET02787 | DBMET00377 | |
| 0.096 | 0.026 | 0.096 | Viral attachment inhibitor | 0.092 0.031 DBMET00377 0.085 0.04 DBMET02787 0.074 0.065 DBMET02792 | ||
| 0.121 | 0.055 | 0.121 | Calcium channel (voltage-sensitive) blocker | |||
| 0.13 | 0.065 | 0.186 | Glutamate receptor antagonist | 0.166 0.041 DBMET00377 0.186 0.03 DBMET02787 | DBMET02787 | |
| 0.072 | 0.01 | 0.072 | G protein-coupled receptor agonist | |||
| 0.077 | 0.014 | 0.077 | 5 Hydroxytryptamine 4 antagonist | 0.074 0.015 DBMET00377 | ||
| 0.075 | 0.014 | 0.075 | Oleamide hydrolase inhibitor | |||
| 0.134 | 0.074 | 0.183 | Nav1.6 sodium channel blocker | 0.183 0.026 DBMET00377 0.146 0.058 DBMET02787 | DBMET00377 | |
| 0.104 | 0.044 | 0.317 | 5 Hydroxytryptamine 2A antagonist | 0.317 0.01 DBMET00377 0.141 0.031 DBMET02787 | DBMET00377 | |
| 0.085 | 0.027 | 0.085 | Acetylcholine M2 receptor antagonist | 0.06 0.045 DBMET00377 | ||
| 0.132 | 0.075 | 0.132 | Calcium channel blocker | |||
| 0.121 | 0.066 | 0.121 | Acetylcholine muscarinic antagonist | 0.111 0.077 DBMET00377 | ||
| 0.187 | 0.132 | 0.187 | Cardiotonic | |||
| 0.078 | 0.025 | 0.289 | Alpha 2 adrenoreceptor agonist | 0.289 0.004 DBMET00377 0.169 0.005 DBMET02787 | DBMET00377 | |
| 0.063 | 0.01 | 0.063 | Benzodiazepine antagonist | 0.049 0.029 DBMET00377 | ||
| 0.11 | 0.057 | 0.188 | Alpha 2c adrenoreceptor antagonist | 0.188 0.02 DBMET00377 0.132 0.041 DBMET02787 | DBMET00377 | |
| 0.082 | 0.03 | 0.244 | 5 Hydroxytryptamine 7 antagonist | 0.244 0.008 DBMET00377 0.12 0.022 DBMET02787 | DBMET00377 | |
| 0.171 | 0.12 | 0.286 | Potassium channel (Voltage-sensitive) blocker | 0.286 0.054 DBMET00377 0.172 0.119 DBMET02787 | DBMET00377 | |
| 0.064 | 0.014 | 0.064 | Cholesterol esterase inhibitor | |||
| 0.059 | 0.008 | 0.059 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.131 | 0.081 | 0.131 | Farnesoid X receptor antagonist | 0.127 0.089 DBMET02787 | ||
| 0.115 | 0.068 | 0.42 | 5 Hydroxytryptamine antagonist | 0.42 0.01 DBMET00377 0.17 0.042 DBMET02787 | DBMET00377 | |
| 0.202 | 0.155 | 0.202 | Nootropic | |||
| 0.071 | 0.026 | 0.071 | Calcium channel P-type blocker | |||
| 0.068 | 0.024 | 0.068 | Autotaxin inhibitor | |||
| 0.093 | 0.05 | 0.093 | Phosphodiesterase IV inhibitor | |||
| 0.111 | 0.069 | 0.111 | TRPA1 agonist | |||
| 0.117 | 0.077 | 0.157 | Cholinergic antagonist | 0.141 0.058 DBMET00377 0.157 0.048 DBMET02787 | DBMET02787 | |
| 0.075 | 0.037 | 0.166 | 5 Hydroxytryptamine 1B antagonist | 0.166 0.011 DBMET00377 0.071 0.04 DBMET02787 | DBMET00377 | |
| 0.078 | 0.039 | 0.286 | Alpha adrenoreceptor agonist | 0.286 0.005 DBMET00377 0.169 0.013 DBMET02787 | DBMET00377 | |
| 0.058 | 0.021 | 0.156 | Histamine H4 receptor antagonist | 0.156 0.004 DBMET00377 0.067 0.014 DBMET02787 | DBMET00377 | |
| 0.072 | 0.038 | 0.072 | Purinergic P2 antagonist | |||
| 0.09 | 0.056 | 0.168 | Histamine N-methyltransferase inhibitor | 0.168 0.009 DBMET00377 0.122 0.028 DBMET02787 | DBMET00377 | |
| 0.175 | 0.142 | 0.176 | RNA-directed DNA polymerase inhibitor | 0.176 0.14 DBMET00377 | DBMET00377 | |
| 0.095 | 0.061 | 0.095 | Bile acid receptor antagonist | 0.089 0.075 DBMET00377 0.095 0.06 DBMET02787 | ||
| 0.076 | 0.043 | 0.14 | Glycine receptor agonist | 0.14 0.008 DBMET00377 0.134 0.009 DBMET02787 0.117 0.013 DBMET02792 | DBMET00377 | |
| 0.066 | 0.033 | 0.081 | Prolactin release inhibitor | 0.081 0.01 DBMET00377 0.077 0.013 DBMET02787 | DBMET00377 | |
| 0.055 | 0.022 | 0.063 | Dopamine D5 antagonist | 0.063 0.018 DBMET00377 0.062 0.018 DBMET02787 | DBMET00377 | |
| 0.084 | 0.052 | 0.093 | Transforming growth factor beta 3 antagonist | 0.093 0.033 DBMET00377 | DBMET00377 | |
| 0.106 | 0.074 | 0.132 | Nav1.5 sodium channel blocker | 0.132 0.041 DBMET00377 | DBMET00377 | |
| 0.051 | 0.02 | 0.051 | Glutamate (mGluR1a) antagonist | |||
| 0.106 | 0.075 | 0.147 | Interleukin 1b antagonist | 0.147 0.042 DBMET00377 0.093 0.09 DBMET02792 | DBMET00377 | |
| 0.1 | 0.07 | 0.1 | Mediator release inhibitor | |||
| 0.054 | 0.024 | 0.113 | Dopamine D2 agonist | 0.104 0.01 DBMET00377 0.113 0.009 DBMET02787 0.068 0.018 DBMET02792 | DBMET02787 | |
| 0.109 | 0.08 | 0.151 | Acetylcholine antagonist | 0.135 0.059 DBMET00377 0.151 0.049 DBMET02787 | DBMET02787 | |
| 0.087 | 0.058 | 0.289 | Alpha 2 adrenoreceptor antagonist | 0.289 0.009 DBMET00377 0.199 0.018 DBMET02787 | DBMET00377 | |
| 0.036 | 0.01 | 0.036 | Purinergic P2Y12 antagonist | |||
| 0.245 | 0.219 | 0.664 | Cyclophilin D inhibitor | 0.664 0.018 DBMET02792 | DBMET02792 | |
| 0.051 | 0.027 | 0.247 | 5 Hydroxytryptamine 2C agonist | 0.247 0.004 DBMET00377 0.159 0.005 DBMET02787 0.052 0.026 DBMET02792 | DBMET00377 | |
| 0.057 | 0.033 | 0.086 | GABA A receptor antagonist | 0.086 0.02 DBMET00377 | DBMET00377 | |
| 0.214 | 0.192 | 0.324 | Calcium channel activator | 0.324 0.069 DBMET00377 0.289 0.104 DBMET02787 | DBMET00377 | |
| 0.25 | 0.228 | 0.382 | 5 Hydroxytryptamine release inhibitor | 0.303 0.162 DBMET00377 0.273 0.198 DBMET02787 0.382 0.09 DBMET02792 | DBMET02792 | |
| 0.045 | 0.024 | 0.057 | Antidiuretic hormone antagonist | 0.057 0.02 DBMET00377 | DBMET00377 | |
| 0.151 | 0.13 | 0.259 | HERG channel blocker | 0.259 0.063 DBMET00377 0.16 0.121 DBMET02787 | DBMET00377 | |
| 0.054 | 0.033 | 0.309 | 5 Hydroxytryptamine 2 agonist | 0.309 0.003 DBMET00377 0.194 0.004 DBMET02787 | DBMET00377 | |
| 0.119 | 0.098 | 0.197 | Activin receptor-like kinase 2 inhibitor | 0.197 0.038 DBMET00377 0.19 0.041 DBMET02787 | DBMET00377 | |
| 0.105 | 0.087 | 0.105 | Calcium channel N-type blocker | |||
| 0.156 | 0.138 | 0.285 | Platelet antagonist | 0.285 0.058 DBMET02792 | DBMET02792 | |
| 0.042 | 0.025 | 0.05 | Acid-sensing ion channel blocker | 0.05 0.017 DBMET00377 0.042 0.026 DBMET02787 | DBMET00377 | |
| 0.046 | 0.029 | 0.046 | Histamine H3 receptor antagonist | |||
| 0.054 | 0.038 | 0.088 | GABA receptor antagonist | 0.088 0.019 DBMET00377 0.048 0.047 DBMET02787 | DBMET00377 | |
| 0.054 | 0.038 | 0.105 | Lysine-specific demethylase 1A inhibitor | 0.105 0.006 DBMET00377 0.096 0.008 DBMET02787 | DBMET00377 | |
| 0.067 | 0.051 | 0.067 | Elastase 1 inhibitor | |||
| 0.064 | 0.05 | 0.064 | Phosphodiesterase 4B inhibitor | |||
| 0.035 | 0.021 | 0.035 | ADAM10 endopeptidase inhibitor | |||
| 0.043 | 0.031 | 0.066 | Alpha 1L adrenoreceptor agonist | 0.066 0.006 DBMET00377 0.055 0.011 DBMET02787 | DBMET00377 | |
| 0.039 | 0.027 | 0.253 | 5 Hydroxytryptamine 2B agonist | 0.253 0.002 DBMET00377 0.158 0.003 DBMET02787 | DBMET00377 | |
| 0.034 | 0.024 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.024 | 0.015 | 0.024 | CC chemokine 8 receptor antagonist | |||
| 0.068 | 0.06 | 0.354 | Alpha 2a adrenoreceptor antagonist | 0.354 0.005 DBMET00377 0.25 0.009 DBMET02787 | DBMET00377 | |
| 0.076 | 0.069 | 0.097 | Ca(v)2.2 blocker | 0.097 0.051 DBMET00377 | DBMET00377 | |
| 0.012 | 0.008 | 0.012 | Glucose-dependent insulinotropic receptor antagonist | |||
| 0.026 | 0.023 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.036 0.011 DBMET00377 0.032 0.015 DBMET02787 | DBMET00377 | |
| 0.035 | 0.032 | 0.035 | Vascular adhesion protein 1 inhibitor | |||
| 0.101 | 0.098 | 0.129 | Sphingosine 1-phosphate receptor 2 agonist | 0.129 0.043 DBMET00377 0.113 0.067 DBMET02787 | DBMET00377 | |
| 0.051 | 0.049 | 0.122 | Dopamine D4 antagonist | 0.122 0.021 DBMET00377 0.053 0.046 DBMET02787 | DBMET00377 | |
| 0.018 | 0.017 | 0.018 | Purinergic P2T antagonist | |||
| 0.041 | 0.04 | 0.041 | Glutamate (mGluR5) antagonist | |||
| 0.028 | 0.028 | 0.058 | Vasopressin 2 antagonist | 0.058 0.012 DBMET00377 0.03 0.025 DBMET02787 | DBMET00377 | |
| 0.118 | 0.119 | 0.329 | NOS3 expression enhancer | 0.155 0.067 DBMET00377 0.196 0.043 DBMET02787 0.329 0.014 DBMET02792 | DBMET02792 | |
| 0.04 | 0.042 | 0.097 | Histamine H1 receptor agonist | 0.097 0.002 DBMET00377 0.058 0.01 DBMET02787 | DBMET00377 | |
| 0.042 | 0.047 | 0.048 | Bromodomain-containing protein 3 inhibitor | 0.048 0.036 DBMET00377 | DBMET00377 | |
| 0.019 | 0.024 | 0.03 | Dopamine D1 agonist | 0.028 0.01 DBMET00377 0.03 0.009 DBMET02787 0.03 0.009 DBMET02792 | DBMET02792 | |
| 0.045 | 0.052 | 0.088 | Protein kinase C eta inhibitor | 0.088 0.02 DBMET00377 0.077 0.025 DBMET02787 0.058 0.036 DBMET02792 | DBMET00377 | |
| 0.037 | 0.044 | 0.063 | GABA B receptor antagonist | 0.063 0.011 DBMET00377 0.044 0.028 DBMET02787 | DBMET00377 | |
| 0.06 | 0.068 | 0.118 | CXC chemokine receptor antagonist | 0.118 0.018 DBMET00377 | DBMET00377 | |
| 0.05 | 0.059 | 0.064 | Acetylcholine M5 receptor antagonist | 0.064 0.037 DBMET00377 | DBMET00377 | |
| 0.029 | 0.037 | 0.08 | 5 Hydroxytryptamine 3B antagonist | 0.08 0.007 DBMET00377 | DBMET00377 | |
| 0.012 | 0.023 | 0.021 | Nicotinic alpha4 receptor agonist | 0.021 0.006 DBMET00377 0.019 0.008 DBMET02787 | DBMET00377 | |
| 0.057 | 0.068 | 0.188 | 5 Hydroxytryptamine 1 antagonist | 0.188 0.018 DBMET00377 0.075 0.05 DBMET02787 | DBMET00377 | |
| 0.07 | 0.082 | 0.213 | Alpha adrenoreceptor antagonist | 0.213 0.026 DBMET00377 0.131 0.043 DBMET02787 | DBMET00377 | |
| 0.034 | 0.047 | 0.076 | Phenylethanolamine N methyltransferase inhibitor | 0.076 0.004 DBMET00377 0.068 0.005 DBMET02787 0.04 0.028 DBMET02792 | DBMET00377 | |
| 0.077 | 0.091 | 0.098 | Sphingomyelinase inhibitor | 0.098 0.061 DBMET00377 | DBMET00377 | |
| 0.055 | 0.069 | 0.178 | Dopamine antagonist | 0.178 0.021 DBMET00377 0.11 0.035 DBMET02787 | DBMET00377 | |
| 0.042 | 0.059 | 0.051 | Phosphodiesterase 4C inhibitor | 0.051 0.044 DBMET00377 | DBMET00377 | |
| 0.03 | 0.049 | 0.043 | Factor XIa inhibitor | 0.043 0.026 DBMET00377 | DBMET00377 | |
| 0.042 | 0.061 | 0.139 | 5 Hydroxytryptamine 3 antagonist | 0.139 0.01 DBMET00377 | DBMET00377 | |
| 0.05 | 0.071 | 0.098 | 5 Hydroxytryptamine 3 agonist | 0.098 0.016 DBMET00377 | DBMET00377 | |
| 0.037 | 0.06 | 0.075 | Dopamine D4 agonist | 0.075 0.021 DBMET00377 0.07 0.023 DBMET02787 | DBMET00377 | |
| 0.046 | 0.069 | 0.15 | 5 Hydroxytryptamine 1A antagonist | 0.15 0.02 DBMET00377 0.061 0.052 DBMET02787 | DBMET00377 | |
| 0.058 | 0.081 | 0.137 | Nicotinic alpha4beta2 receptor antagonist | 0.137 0.011 DBMET00377 0.106 0.027 DBMET02787 | DBMET00377 | |
| 0.042 | 0.065 | 0.171 | 5 Hydroxytryptamine 6 antagonist | 0.171 0.005 DBMET00377 0.09 0.018 DBMET02787 | DBMET00377 | |
| 0.149 | 0.174 | 0.269 | DNA damaging | 0.196 0.118 DBMET00377 0.254 0.078 DBMET02787 0.269 0.071 DBMET02792 | DBMET02792 | |
| 0.05 | 0.075 | 0.06 | Phosphodiesterase 1A inhibitor | 0.06 0.04 DBMET00377 | DBMET00377 | |
| 0.082 | 0.108 | 0.095 | Hedgehog signaling inhibitor | 0.095 0.073 DBMET00377 | DBMET00377 | |
| 0.072 | 0.099 | 0.241 | Topoisomerase I inhibitor | 0.098 0.072 DBMET00377 0.153 0.04 DBMET02787 0.241 0.018 DBMET02792 | DBMET02792 | |
| 0.12 | 0.147 | 0.355 | Psychostimulant | 0.339 0.034 DBMET00377 0.298 0.043 DBMET02787 0.355 0.03 DBMET02792 | DBMET02792 | |
| 0.02 | 0.049 | 0.031 | Purinergic P2Y14 antagonist | 0.031 0.02 DBMET00377 | DBMET00377 | |
| 0.155 | 0.184 | 0.318 | 5 Hydroxytryptamine 1E antagonist | 0.318 0.02 DBMET00377 0.286 0.04 DBMET02787 | DBMET00377 | |
| 0.058 | 0.088 | 0.065 | MDM2 inhibitor | 0.065 0.056 DBMET00377 | DBMET00377 | |
| 0.021 | 0.051 | 0.075 | 5 Hydroxytryptamine 6 agonist | 0.075 0.003 DBMET00377 0.034 0.012 DBMET02787 | DBMET00377 | |
| 0.067 | 0.097 | 0.09 | MAO A inhibitor | 0.09 0.071 DBMET00377 | DBMET00377 | |
| 0.082 | 0.113 | 0.18 | Protein kinase C gamma inhibitor | 0.18 0.019 DBMET00377 0.174 0.021 DBMET02787 | DBMET00377 | |
| 0.044 | 0.076 | 0.318 | 5 Hydroxytryptamine agonist | 0.318 0.008 DBMET00377 0.156 0.02 DBMET02787 | DBMET00377 | |
| 0.035 | 0.068 | 0.051 | Purinergic P2X4 antagonist | 0.051 0.023 DBMET00377 0.043 0.038 DBMET02787 | DBMET00377 | |
| 0.039 | 0.076 | 0.099 | Dopamine D3 antagonist | 0.099 0.025 DBMET00377 | DBMET00377 | |
| 0.038 | 0.077 | 0.137 | NMDA 2B receptor antagonist | 0.137 0.01 DBMET02787 | DBMET02787 | |
| 0.046 | 0.087 | 0.107 | Cyclin B3 inhibitor | 0.107 0.026 DBMET00377 0.087 0.034 DBMET02787 | DBMET00377 | |
| 0.04 | 0.082 | 0.117 | Nicotinic alpha3beta2 receptor antagonist | 0.117 0.005 DBMET00377 0.091 0.01 DBMET02787 | DBMET00377 | |
| 0.038 | 0.083 | 0.136 | Alpha 1a adrenoreceptor antagonist | 0.136 0.026 DBMET00377 0.079 0.045 DBMET02787 | DBMET00377 | |
| 0.069 | 0.116 | 0.086 | Hematopoietic | 0.086 0.057 DBMET00377 | DBMET00377 | |
| 0.087 | 0.135 | 0.175 | Sodium channel blocker | 0.175 0.043 DBMET00377 0.115 0.09 DBMET02787 | DBMET00377 | |
| 0.034 | 0.082 | 0.135 | Dopamine D2 antagonist | 0.135 0.024 DBMET00377 0.08 0.04 DBMET02787 | DBMET00377 | |
| 0.048 | 0.096 | 0.127 | Protein kinase C alpha inhibitor | 0.127 0.014 DBMET00377 0.078 0.036 DBMET02787 | DBMET00377 | |
| 0.044 | 0.093 | 0.072 | Potassium channel (Ca-activated) blocker | 0.072 0.024 DBMET00377 | DBMET00377 | |
| 0.041 | 0.091 | 0.096 | 5 Hydroxytryptamine 3A antagonist | 0.096 0.019 DBMET00377 | DBMET00377 | |
| 0.011 | 0.061 | 0.032 | Alpha 2b adrenoreceptor agonist | 0.032 0.004 DBMET00377 | DBMET00377 | |
| 0.009 | 0.059 | 0.038 | Alpha 2c adrenoreceptor agonist | 0.038 0.004 DBMET00377 | DBMET00377 | |
| 0.05 | 0.1 | 0.165 | MAP-kinase-activated kinase 2 inhibitor | 0.165 0.008 DBMET00377 0.145 0.012 DBMET02787 | DBMET00377 | |
| 0.038 | 0.088 | 0.084 | 5 Hydroxytryptamine 1D antagonist | 0.084 0.029 DBMET00377 | DBMET00377 | |
| 0.057 | 0.11 | 0.177 | MAP-kinase-activated kinase inhibitor | 0.177 0.008 DBMET00377 0.154 0.014 DBMET02787 | DBMET00377 | |
| 0.071 | 0.124 | 0.211 | GABA C receptor rho-1 antagonist | 0.211 0.007 DBMET00377 0.189 0.01 DBMET02787 | DBMET00377 | |
| 0.096 | 0.151 | 0.341 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.341 0.028 DBMET00377 0.318 0.032 DBMET02787 | DBMET00377 | |
| 0.055 | 0.111 | 0.121 | Antiadrenergic | 0.121 0.045 DBMET00377 0.098 0.057 DBMET02787 | DBMET00377 | |
| 0.014 | 0.07 | 0.049 | Nicotinic alpha3beta4 receptor agonist | 0.049 0.005 DBMET00377 0.033 0.017 DBMET02787 | DBMET00377 | |
| 0.053 | 0.111 | 0.117 | Adrenaline antagonist | 0.117 0.045 DBMET00377 0.094 0.057 DBMET02787 | DBMET00377 | |
| 0.039 | 0.098 | 0.148 | Alpha 1 adrenoreceptor antagonist | 0.148 0.03 DBMET00377 0.082 0.052 DBMET02787 | DBMET00377 | |
| 0.039 | 0.099 | 0.176 | 5 Hydroxytryptamine 7 agonist | 0.176 0.004 DBMET00377 0.136 0.005 DBMET02787 | DBMET00377 | |
| 0.033 | 0.096 | 0.126 | CXC chemokine 4 receptor antagonist | 0.126 0.019 DBMET00377 | DBMET00377 | |
| 0.046 | 0.111 | 0.065 | Phosphodiesterase 1C inhibitor | 0.065 0.037 DBMET00377 | DBMET00377 | |
| 0.031 | 0.096 | 0.075 | Alpha 1 adrenoreceptor agonist | 0.075 0.025 DBMET00377 | DBMET00377 | |
| 0.113 | 0.18 | 0.196 | Potassium channel blocker | 0.196 0.095 DBMET00377 | DBMET00377 | |
| 0.032 | 0.103 | 0.2 | 5 Hydroxytryptamine 2A agonist | 0.2 0.004 DBMET00377 0.164 0.005 DBMET02787 | DBMET00377 | |
| 0.033 | 0.104 | 0.089 | Alpha 1b adrenoreceptor antagonist | 0.089 0.04 DBMET00377 | DBMET00377 | |
| 0.05 | 0.121 | 0.066 | Exportin-1 inhibitor | 0.066 0.053 DBMET00377 | DBMET00377 | |
| 0.023 | 0.095 | 0.067 | Alpha 1d adrenoreceptor antagonist | 0.067 0.036 DBMET00377 | DBMET00377 | |
| 0.026 | 0.098 | 0.045 | Glutamate (mGluR5) agonist | 0.045 0.033 DBMET00377 | DBMET00377 | |
| 0.17 | 0.244 | 0.209 | Toll-Like receptor 7 agonist | 0.206 0.194 DBMET00377 0.209 0.19 DBMET02787 0.208 0.192 DBMET02792 | DBMET02787 | |
| 0.021 | 0.094 | 0.08 | AMPA receptor antagonist | 0.08 0.017 DBMET00377 0.057 0.026 DBMET02787 | DBMET00377 | |
| 0.05 | 0.125 | 0.283 | NMDA receptor antagonist | 0.131 0.031 DBMET00377 0.283 0.007 DBMET02787 | DBMET02787 | |
| 0.148 | 0.224 | 0.182 | Hypoxia-inducible factor 1 alpha inhibitor | 0.182 0.176 DBMET02792 | DBMET02792 | |
| 0.055 | 0.131 | 0.079 | GABA A receptor agonist | 0.079 0.064 DBMET00377 | DBMET00377 | |
| 0.157 | 0.234 | 0.236 | Tyrosine 3 hydroxylase inhibitor | 0.217 0.107 DBMET00377 0.236 0.083 DBMET02787 | DBMET02787 | |
| 0.041 | 0.119 | 0.093 | Corticotropin releasing factor 2 receptor antagonist | 0.093 0.009 DBMET00377 | DBMET00377 | |
| 0.013 | 0.091 | 0.036 | Dopamine D3 agonist | 0.036 0.032 DBMET02787 | DBMET02787 | |
| 0.054 | 0.137 | 0.094 | MAP kinase kinase kinase inhibitor | 0.094 0.072 DBMET00377 | DBMET00377 | |
| 0.077 | 0.161 | 0.186 | Cell adhesion inhibitor | 0.186 0.029 DBMET02792 | DBMET02792 | |
| 0.036 | 0.122 | 0.057 | Phosphodiesterase 1B inhibitor | 0.057 0.047 DBMET00377 | DBMET00377 | |
| 0.062 | 0.15 | 0.097 | Nitric-oxide synthase inhibitor | 0.097 0.064 DBMET00377 | DBMET00377 | |
| 0.164 | 0.252 | 0.22 | Toll-Like receptor agonist | 0.204 0.197 DBMET02787 0.22 0.179 DBMET02792 | DBMET02792 | |
| 0.074 | 0.162 | 0.176 | Sodium channel (voltage-gated) blocker | 0.176 0.039 DBMET00377 0.119 0.085 DBMET02787 | DBMET00377 | |
| 0.033 | 0.125 | 0.12 | Adrenaline uptake inhibitor | 0.12 0.014 DBMET00377 0.079 0.027 DBMET02787 | DBMET00377 | |
| 0.017 | 0.111 | 0.043 | Glutamate (mGluR group I) agonist | 0.043 0.039 DBMET00377 | DBMET00377 | |
| 0.064 | 0.158 | 0.17 | MAP kinase 12 inhibitor | 0.17 0.032 DBMET00377 0.118 0.072 DBMET02787 | DBMET00377 | |
| 0.017 | 0.112 | 0.037 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.037 0.026 DBMET00377 | DBMET00377 | |
| 0.064 | 0.16 | 0.222 | GABA C receptor antagonist | 0.222 0.009 DBMET00377 0.213 0.01 DBMET02787 | DBMET00377 | |
| 0.091 | 0.186 | 0.205 | Cyclin-dependent kinase 8 inhibitor | 0.205 0.032 DBMET00377 0.2 0.035 DBMET02787 | DBMET00377 | |
| 0.109 | 0.206 | 0.277 | ATPase inhibitor | 0.151 0.1 DBMET00377 0.141 0.119 DBMET02787 0.277 0.009 DBMET02792 | DBMET02792 | |
| 0.1 | 0.197 | 0.148 | Tumour necrosis factor antagonist | 0.148 0.104 DBMET00377 | DBMET00377 | |
| 0.022 | 0.122 | 0.047 | Poly(ADP-ribose) polymerase inhibitor | 0.047 0.027 DBMET00377 | DBMET00377 | |
| 0.031 | 0.131 | 0.094 | Protein kinase C iota inhibitor | 0.094 0.02 DBMET00377 0.064 0.037 DBMET02787 | DBMET00377 | |
| 0.075 | 0.177 | 0.286 | Protein kinase C nu inhibitor | 0.286 0.027 DBMET00377 0.232 0.038 DBMET02787 | DBMET00377 | |
| 0.059 | 0.162 | 0.122 | Estrogen receptor beta antagonist | 0.122 0.03 DBMET02787 | DBMET02787 | |
| 0.059 | 0.165 | 0.157 | MAP kinase 13 inhibitor | 0.157 0.033 DBMET00377 0.105 0.073 DBMET02787 | DBMET00377 | |
| 0.05 | 0.159 | 0.102 | Cell adhesion molecule inhibitor | 0.102 0.033 DBMET02792 | DBMET02792 | |
| 0.022 | 0.132 | 0.075 | Protein kinase C epsilon inhibitor | 0.075 0.022 DBMET00377 | DBMET00377 | |
| 0.081 | 0.191 | 0.185 | Diuretic | 0.185 0.051 DBMET02792 | DBMET02792 | |
| 0.05 | 0.16 | 0.129 | Protein kinase C delta inhibitor | 0.129 0.031 DBMET00377 0.101 0.051 DBMET02787 | DBMET00377 | |
| 0.041 | 0.152 | 0.1 | Acetylcholine nicotinic agonist | 0.1 0.037 DBMET00377 0.087 0.049 DBMET02787 | DBMET00377 | |
| 0.018 | 0.13 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.018 DBMET02787 | DBMET02787 | |
| 0.042 | 0.158 | 0.063 | Transforming growth factor antagonist | 0.063 0.061 DBMET00377 | DBMET00377 | |
| 0.033 | 0.151 | 0.081 | Nav1.7 sodium channel blocker | 0.081 0.033 DBMET00377 | DBMET00377 | |
| 0.024 | 0.143 | 0.047 | Transforming growth factor beta 1 antagonist | 0.047 0.037 DBMET00377 | DBMET00377 | |
| 0.036 | 0.156 | 0.087 | Protein kinase B beta inhibitor | 0.087 0.035 DBMET00377 0.078 0.045 DBMET02787 | DBMET00377 | |
| 0.065 | 0.186 | 0.142 | Activin receptor-like kinase 4 inhibitor | 0.142 0.033 DBMET00377 0.103 0.079 DBMET02787 | DBMET00377 | |
| 0.024 | 0.145 | 0.088 | Nicotinic receptor alpha4 subunit antagonist | 0.061 0.021 DBMET00377 0.088 0.01 DBMET02787 | DBMET02787 | |
| 0.019 | 0.14 | 0.114 | 5 Hydroxytryptamine uptake inhibitor | 0.114 0.022 DBMET00377 0.061 0.045 DBMET02787 | DBMET00377 | |
| 0.022 | 0.143 | 0.058 | Nicotinic neuronal receptor agonist | 0.058 0.037 DBMET00377 | DBMET00377 | |
| 0.024 | 0.146 | 0.075 | Histamine agonist | 0.075 0.016 DBMET00377 | DBMET00377 | |
| 0.024 | 0.146 | 0.056 | Dopamine uptake inhibitor | 0.056 0.042 DBMET00377 | DBMET00377 | |
| 0.019 | 0.153 | 0.04 | Nicotinic receptor alpha3 subunit antagonist | 0.04 0.035 DBMET00377 | DBMET00377 | |
| 0.02 | 0.155 | 0.168 | NMDA 2 receptor antagonist | 0.168 0.013 DBMET02787 | DBMET02787 | |
| 0.031 | 0.168 | 0.085 | Rho-associated kinase I inhibitor | 0.085 0.042 DBMET00377 | DBMET00377 | |
| 0.023 | 0.16 | 0.076 | Potassium channel small-conductance Ca-activated blocker | 0.076 0.011 DBMET00377 0.042 0.036 DBMET02787 | DBMET00377 | |
| 0.084 | 0.221 | 0.142 | Neuropeptide Y1 antagonist | 0.142 0.077 DBMET00377 | DBMET00377 | |
| 0.094 | 0.233 | 0.174 | MAP kinase 3 inhibitor | 0.174 0.039 DBMET00377 0.129 0.11 DBMET02787 | DBMET00377 | |
| 0.1 | 0.242 | 0.161 | MAP kinase kinase 4 inhibitor | 0.158 0.048 DBMET00377 0.161 0.043 DBMET02787 | DBMET02787 | |
| 0.045 | 0.188 | 0.095 | HIV-1 integrase (Overall Integration) inhibitor | 0.095 0.059 DBMET00377 0.091 0.064 DBMET02787 | DBMET00377 | |
| 0.025 | 0.168 | 0.082 | Neuronal nicotinic receptor antagonist | 0.082 0.035 DBMET00377 0.078 0.038 DBMET02787 | DBMET00377 | |
| 0.018 | 0.162 | 0.041 | Nerve growth factor antagonist | 0.041 0.032 DBMET00377 | DBMET00377 | |
| 0.176 | 0.321 | 0.235 | Calcium channel L-type activator | 0.235 0.222 DBMET02787 | DBMET02787 | |
| 0.092 | 0.239 | 0.266 | Non-steroidal antiinflammatory agent | 0.143 0.126 DBMET00377 0.266 0.037 DBMET02792 | DBMET02792 | |
| 0.063 | 0.211 | 0.128 | Estrogen antagonist | 0.128 0.04 DBMET02787 | DBMET02787 | |
| 0.174 | 0.325 | 0.339 | MAP kinase kinase 6 inhibitor | 0.339 0.101 DBMET00377 0.227 0.222 DBMET02787 | DBMET00377 | |
| 0.044 | 0.2 | 0.11 | DNA intercalator | 0.11 0.065 DBMET02792 | DBMET02792 | |
| 0.08 | 0.238 | 0.161 | Polo-like kinase-3 inhibitor | 0.161 0.073 DBMET00377 0.132 0.107 DBMET02787 | DBMET00377 | |
| 0.029 | 0.189 | 0.09 | Acetylcholine nicotinic antagonist | 0.09 0.046 DBMET00377 0.087 0.048 DBMET02787 | DBMET00377 | |
| 0.006 | 0.166 | 0.044 | Imidazoline I1 receptor antagonist | 0.044 0.004 DBMET00377 0.019 0.018 DBMET02787 | DBMET00377 | |
| 0.014 | 0.175 | 0.081 | NMDA 2C receptor antagonist | 0.081 0.025 DBMET00377 0.08 0.025 DBMET02787 | DBMET00377 | |
| 0.05 | 0.212 | 0.133 | Nav1.3 sodium channel blocker | 0.133 0.061 DBMET00377 | DBMET00377 | |
| 0.042 | 0.206 | 0.166 | Protein kinase C mu inhibitor | 0.166 0.02 DBMET00377 0.127 0.037 DBMET02787 | DBMET00377 | |
| 0.034 | 0.201 | 0.075 | Protein kinase B gamma inhibitor | 0.075 0.052 DBMET00377 | DBMET00377 | |
| 0.025 | 0.192 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.067 0.018 DBMET02792 | DBMET02792 | |
| 0.024 | 0.196 | 0.129 | Check point kinase 1 inhibitor | 0.129 0.018 DBMET00377 0.122 0.02 DBMET02787 | DBMET00377 | |
| 0.019 | 0.191 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | 0.049 0.048 DBMET00377 | DBMET00377 | |
| 0.157 | 0.331 | 0.259 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.259 0.055 DBMET00377 0.219 0.118 DBMET02787 | DBMET00377 | |
| 0.047 | 0.225 | 0.197 | Protein kinase C zeta inhibitor | 0.162 0.017 DBMET00377 0.197 0.012 DBMET02787 | DBMET02787 | |
| 0.028 | 0.208 | 0.125 | Topoisomerase II alpha inhibitor | 0.125 0.028 DBMET02792 | DBMET02792 | |
| 0.089 | 0.271 | 0.275 | Vasodilator | 0.275 0.057 DBMET02792 | DBMET02792 | |
| 0.104 | 0.286 | 0.149 | Cyclin-dependent kinase 3 inhibitor | 0.149 0.097 DBMET00377 | DBMET00377 | |
| 0.082 | 0.266 | 0.23 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.23 0.063 DBMET00377 0.187 0.083 DBMET02787 | DBMET00377 | |
| 0.042 | 0.227 | 0.095 | Insulin receptor antagonist | 0.095 0.069 DBMET00377 | DBMET00377 | |
| 0.029 | 0.217 | 0.153 | Protein kinase A inhibitor | 0.142 0.027 DBMET00377 0.153 0.024 DBMET02787 | DBMET02787 | |
| 0.052 | 0.24 | 0.196 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.196 0.047 DBMET00377 0.145 0.068 DBMET02787 | DBMET00377 | |
| 0.037 | 0.225 | 0.06 | Lipocortins synthesis agonist | 0.06 0.037 DBMET02792 | DBMET02792 | |
| 0.111 | 0.303 | 0.233 | Cholesterol antagonist | 0.233 0.138 DBMET02792 | DBMET02792 | |
| 0.02 | 0.212 | 0.076 | MAP kinase 11 inhibitor | 0.076 0.051 DBMET00377 | DBMET00377 | |
| 0.077 | 0.272 | 0.145 | Adenylate cyclase stimulant | 0.134 0.094 DBMET00377 0.145 0.071 DBMET02787 | DBMET02787 | |
| 0.029 | 0.224 | 0.098 | Protein kinase B alpha inhibitor | 0.067 0.05 DBMET00377 0.098 0.031 DBMET02787 | DBMET02787 | |
| 0.096 | 0.292 | 0.471 | Hypoglycemic | 0.471 0.018 DBMET02792 | DBMET02792 | |
| 0.065 | 0.262 | 0.163 | Protein kinase (CK1) gamma 3 inhibitor | 0.161 0.078 DBMET00377 0.163 0.076 DBMET02787 | DBMET02787 | |
| 0.06 | 0.263 | 0.167 | Protein kinase stimulant | 0.167 0.057 DBMET02792 | DBMET02792 | |
| 0.033 | 0.236 | 0.075 | I kappa B kinase 1 inhibitor | 0.075 0.041 DBMET00377 | DBMET00377 | |
| 0.021 | 0.225 | 0.135 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.135 0.023 DBMET00377 0.125 0.025 DBMET02787 | DBMET00377 | |
| 0.025 | 0.23 | 0.07 | Phospholipase D inhibitor | 0.07 0.054 DBMET00377 | DBMET00377 | |
| 0.03 | 0.239 | 0.117 | Glycine receptor antagonist | 0.076 0.063 DBMET00377 0.075 0.066 DBMET02787 0.117 0.02 DBMET02792 | DBMET02792 | |
| 0.03 | 0.239 | 0.071 | Adrenaline agonist | 0.071 0.07 DBMET02787 | DBMET02787 | |
| 0.004 | 0.213 | 0.025 | NMDA receptor glycine site antagonist | 0.025 0.017 DBMET02787 | DBMET02787 | |
| 0.027 | 0.238 | 0.072 | Heat shock protein 90 beta antagonist | 0.061 0.038 DBMET00377 0.072 0.026 DBMET02787 | DBMET02787 | |
| 0.019 | 0.233 | 0.078 | Protein kinase C beta inhibitor | 0.078 0.034 DBMET00377 | DBMET00377 | |
| 0.054 | 0.269 | 0.086 | T cell inhibitor | 0.086 0.047 DBMET02792 | DBMET02792 | |
| 0.044 | 0.262 | 0.206 | CDC-like kinase 2 inhibitor | 0.154 0.09 DBMET00377 0.206 0.063 DBMET02787 | DBMET02787 | |
| 0.015 | 0.234 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.034 0.021 DBMET00377 0.033 0.024 DBMET02787 | DBMET00377 | |
| 0.023 | 0.242 | 0.062 | Botulinum neurotoxin type A inhibitor | 0.062 0.035 DBMET00377 | DBMET00377 | |
| 0.054 | 0.273 | 0.119 | Nav1.2 sodium channel blocker | 0.119 0.084 DBMET00377 | DBMET00377 | |
| 0.049 | 0.273 | 0.231 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.221 0.062 DBMET00377 0.231 0.056 DBMET02787 0.147 0.123 DBMET02792 | DBMET02787 | |
| 0.05 | 0.275 | 0.087 | Alpha 2d adrenoreceptor antagonist | 0.087 0.08 DBMET00377 | DBMET00377 | |
| 0.093 | 0.32 | 0.221 | Superoxide dismutase inhibitor | 0.221 0.096 DBMET00377 0.191 0.128 DBMET02787 | DBMET00377 | |
| 0.061 | 0.288 | 0.138 | Aurora-C kinase inhibitor | 0.138 0.068 DBMET00377 0.121 0.104 DBMET02787 | DBMET00377 | |
| 0.068 | 0.296 | 0.183 | Aldehyde oxidase inhibitor | 0.183 0.114 DBMET02787 | DBMET02787 | |
| 0.007 | 0.239 | 0.036 | NMDA receptor subunit 3A antagonist | 0.036 0.028 DBMET02787 | DBMET02787 | |
| 0.183 | 0.417 | 0.348 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.348 0.153 DBMET00377 | DBMET00377 | |
| 0.021 | 0.259 | 0.089 | CYP2A6 inhibitor | 0.089 0.042 DBMET00377 | DBMET00377 | |
| 0.049 | 0.288 | 0.13 | Amyloid beta aggregation inhibitor | 0.13 0.126 DBMET02792 | DBMET02792 | |
| 0.034 | 0.273 | 0.095 | Prolactin inhibitor | 0.095 0.06 DBMET02787 | DBMET02787 | |
| 0.011 | 0.252 | 0.059 | NMDA receptor subunit 3B antagonist | 0.059 0.02 DBMET02787 | DBMET02787 | |
| 0.039 | 0.283 | 0.118 | CDC-like kinase 1 inhibitor | 0.118 0.097 DBMET02787 | DBMET02787 | |
| 0.031 | 0.279 | 0.196 | Topoisomerase II inhibitor | 0.196 0.034 DBMET02792 | DBMET02792 | |
| 0.021 | 0.271 | 0.071 | I kappa B kinase 2 inhibitor | 0.071 0.031 DBMET00377 | DBMET00377 | |
| 0.063 | 0.314 | 0.295 | Platelet adhesion inhibitor | 0.295 0.035 DBMET02792 | DBMET02792 | |
| 0.004 | 0.256 | 0.017 | Histamine H4 receptor agonist | 0.017 0.015 DBMET00377 | DBMET00377 | |
| 0.003 | 0.264 | 0.017 | Alpha 2a adrenoreceptor agonist | 0.017 0.013 DBMET00377 | DBMET00377 | |
| 0.027 | 0.293 | 0.059 | Beta 3 adrenoreceptor antagonist | 0.059 0.057 DBMET02787 | DBMET02787 | |
| 0.045 | 0.312 | 0.125 | Protein kinase (CK1) gamma 1 inhibitor | 0.125 0.092 DBMET00377 0.117 0.101 DBMET02787 | DBMET00377 | |
| 0.081 | 0.351 | 0.411 | Transcription factor NF kappa B inhibitor | 0.411 0.061 DBMET02792 | DBMET02792 | |
| 0.025 | 0.295 | 0.104 | I kappa B kinase inhibitor | 0.104 0.035 DBMET00377 0.079 0.061 DBMET02787 | DBMET00377 | |
| 0.031 | 0.302 | 0.09 | Cystathionine beta-synthase inhibitor | 0.09 0.089 DBMET02787 | DBMET02787 | |
| 0.018 | 0.289 | 0.062 | DNA gyrase inhibitor | 0.062 0.046 DBMET02792 | DBMET02792 | |
| 0.025 | 0.299 | 0.066 | Histone deacetylase SIRT1 stimulant | 0.066 0.06 DBMET02792 | DBMET02792 | |
| 0.025 | 0.299 | 0.066 | Histone deacetylase stimulant | 0.066 0.06 DBMET02792 | DBMET02792 | |
| 0.029 | 0.305 | 0.108 | ATPase (Vacuolar H+) inhibitor | 0.108 0.03 DBMET02792 | DBMET02792 | |
| 0.01 | 0.287 | 0.047 | Toll-Like receptor 8 antagonist | 0.047 0.045 DBMET00377 | DBMET00377 | |
| 0.008 | 0.286 | 0.088 | Dopamine D5 agonist | 0.052 0.016 DBMET00377 0.088 0.005 DBMET02787 | DBMET02787 | |
| 0.005 | 0.283 | 0.031 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.012 DBMET02792 | DBMET02792 | |
| 0.144 | 0.427 | 0.695 | Antiinflammatory | 0.401 0.139 DBMET02787 0.695 0.032 DBMET02792 | DBMET02792 | |
| 0.108 | 0.392 | 0.193 | Nitric-oxide synthase stimulant | 0.169 0.155 DBMET00377 0.193 0.102 DBMET02787 0.182 0.124 DBMET02792 | DBMET02787 | |
| 0.092 | 0.378 | 0.137 | CC chemokine 6 receptor antagonist | 0.137 0.046 DBMET02792 | DBMET02792 | |
| 0.054 | 0.344 | 0.196 | Death-associated protein kinase 3 inhibitor | 0.196 0.077 DBMET00377 0.171 0.096 DBMET02787 | DBMET00377 | |
| 0.043 | 0.343 | 0.11 | NADPH oxidase inhibitor | 0.11 0.097 DBMET02787 0.109 0.099 DBMET02792 | DBMET02787 | |
| 0.016 | 0.322 | 0.097 | Protein kinase (CK2) inhibitor | 0.097 0.067 DBMET00377 0.092 0.071 DBMET02787 | DBMET00377 | |
| 0.007 | 0.313 | 0.048 | Alpha 1d adrenoreceptor agonist | 0.048 0.018 DBMET00377 | DBMET00377 | |
| 0.058 | 0.365 | 0.355 | Hemostatic | 0.355 0.011 DBMET02792 | DBMET02792 | |
| 0.077 | 0.385 | 0.392 | Immunosuppressant | 0.392 0.067 DBMET02792 | DBMET02792 | |
| 0.067 | 0.378 | 0.209 | Focal adhesion kinase 2 inhibitor | 0.209 0.063 DBMET00377 0.158 0.119 DBMET02787 | DBMET00377 | |
| 0.029 | 0.344 | 0.135 | 5 Hydroxytryptamine 3A agonist | 0.135 0.045 DBMET00377 0.102 0.073 DBMET02787 | DBMET00377 | |
| 0.029 | 0.345 | 0.134 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.134 0.089 DBMET02787 | DBMET02787 | |
| 0.038 | 0.354 | 0.132 | Toll-Like receptor 4 antagonist | 0.132 0.033 DBMET02792 | DBMET02792 | |
| 0.015 | 0.333 | 0.101 | Protein kinase (CK2) alpha inhibitor | 0.101 0.075 DBMET00377 0.095 0.081 DBMET02787 | DBMET00377 | |
| 0.044 | 0.363 | 0.12 | Heat shock protein 90 antagonist | 0.12 0.113 DBMET00377 | DBMET00377 | |
| 0.058 | 0.378 | 0.141 | Melanin inhibitor | 0.141 0.094 DBMET02792 | DBMET02792 | |
| 0.011 | 0.333 | 0.058 | Pim-2 kinase inhibitor | 0.058 0.033 DBMET00377 | DBMET00377 | |
| 0.043 | 0.368 | 0.13 | Heat shock protein 90 alpha antagonist | 0.13 0.111 DBMET00377 | DBMET00377 | |
| 0.029 | 0.356 | 0.129 | CDC-like kinase 4 inhibitor | 0.129 0.119 DBMET02787 | DBMET02787 | |
| 0.025 | 0.353 | 0.143 | Creatine kinase inhibitor | 0.143 0.027 DBMET02787 | DBMET02787 | |
| 0.019 | 0.349 | 0.097 | Pim-3 kinase inhibitor | 0.097 0.049 DBMET00377 | DBMET00377 | |
| 0.028 | 0.359 | 0.214 | AMP-activated protein kinase stimulant | 0.214 0.009 DBMET02792 | DBMET02792 | |
| 0.033 | 0.365 | 0.09 | Electrolyte absorption antagonist | 0.09 0.075 DBMET00377 | DBMET00377 | |
| 0.023 | 0.355 | 0.102 | Polo-like kinase-4 inhibitor | 0.102 0.075 DBMET00377 | DBMET00377 | |
| 0.037 | 0.373 | 0.193 | Anticoagulant | 0.193 0.056 DBMET02792 | DBMET02792 | |
| 0.047 | 0.386 | 0.256 | Nitric oxide antagonist | 0.256 0.05 DBMET02792 | DBMET02792 | |
| 0.032 | 0.373 | 0.23 | Dyrk kinase inhibitor | 0.159 0.128 DBMET00377 0.23 0.082 DBMET02787 | DBMET02787 | |
| 0.013 | 0.356 | 0.089 | Check point kinase 2 inhibitor | 0.089 0.075 DBMET00377 | DBMET00377 | |
| 0.003 | 0.348 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.025 DBMET00377 | DBMET00377 | |
| 0.025 | 0.37 | 0.118 | Toll-Like receptor 9 antagonist | 0.118 0.088 DBMET00377 | DBMET00377 | |
| 0.028 | 0.373 | 0.153 | Clk dual-specificity kinase inhibitor | 0.153 0.111 DBMET02787 | DBMET02787 | |
| 0.027 | 0.376 | 0.1 | Protein kinase (CK1) gamma 2 inhibitor | 0.1 0.084 DBMET02787 | DBMET02787 | |
| 0.106 | 0.457 | 0.481 | Apoptosis agonist | 0.481 0.08 DBMET02792 | DBMET02792 | |
| 0.027 | 0.381 | 0.127 | Ribosomal protein S6 kinase inhibitor | 0.127 0.084 DBMET00377 0.114 0.098 DBMET02787 | DBMET00377 | |
| 0.028 | 0.388 | 0.073 | GABA B receptor agonist | 0.073 0.06 DBMET02787 | DBMET02787 | |
| 0.005 | 0.366 | 0.031 | Sodium/glucose cotransporter inhibitor | 0.031 0.01 DBMET02792 | DBMET02792 | |
| 0.032 | 0.394 | 0.074 | MAP kinase kinase 7 inhibitor | 0.074 0.066 DBMET02787 | DBMET02787 | |
| 0.015 | 0.382 | 0.1 | Pim-1 kinase inhibitor | 0.1 0.058 DBMET00377 | DBMET00377 | |
| 0.042 | 0.417 | 0.301 | Antiamyloidogenic | 0.301 0.051 DBMET02792 | DBMET02792 | |
| 0.006 | 0.381 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.025 0.016 DBMET02792 | DBMET02792 | |
| 0.045 | 0.421 | 0.257 | Interleukin agonist | 0.257 0.074 DBMET02792 | DBMET02792 | |
| 0.076 | 0.452 | 0.304 | Immunomodulator | 0.304 0.08 DBMET02792 | DBMET02792 | |
| 0.026 | 0.405 | 0.192 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.192 0.098 DBMET02787 | DBMET02787 | |
| 0.037 | 0.417 | 0.19 | Cyclooxygenase 3 inhibitor | 0.19 0.023 DBMET02792 | DBMET02792 | |
| 0.024 | 0.405 | 0.145 | LIM domain kinase 1 inhibitor | 0.145 0.103 DBMET00377 | DBMET00377 | |
| 0.046 | 0.434 | 0.164 | Interleukin 6 antagonist | 0.164 0.07 DBMET02792 | DBMET02792 | |
| 0.018 | 0.408 | 0.11 | Protein kinase (CK1) gamma inhibitor | 0.109 0.104 DBMET00377 0.11 0.102 DBMET02787 | DBMET02787 | |
| 0.025 | 0.415 | 0.053 | Adenine nucleotide translocase inhibitor | 0.053 0.045 DBMET02792 | DBMET02792 | |
| 0.107 | 0.498 | 0.271 | 5 Hydroxytryptamine uptake stimulant | 0.271 0.063 DBMET00377 0.244 0.087 DBMET02787 | DBMET00377 | |
| 0.012 | 0.411 | 0.064 | Myc inhibitor | 0.064 0.024 DBMET00377 0.052 0.042 DBMET02787 | DBMET00377 | |
| 0.027 | 0.428 | 0.195 | MAP kinase kinase 2 inhibitor | 0.195 0.085 DBMET00377 0.165 0.108 DBMET02787 | DBMET00377 | |
| 0.028 | 0.43 | 0.162 | I kappa B kinase epsilon inhibitor | 0.162 0.107 DBMET00377 | DBMET00377 | |
| 0.019 | 0.427 | 0.129 | Vascular endothelial growth factor 3 antagonist | 0.129 0.086 DBMET00377 | DBMET00377 | |
| 0.083 | 0.491 | 0.325 | Apoptosis antagonist | 0.325 0.069 DBMET02792 | DBMET02792 | |
| 0.005 | 0.421 | 0.101 | Antineoplastic antibiotic | 0.101 0.046 DBMET02792 | DBMET02792 | |
| 0.022 | 0.439 | 0.132 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.132 0.092 DBMET02787 | DBMET02787 | |
| 0.065 | 0.486 | 0.155 | Death-associated protein kinase 2 inhibitor | 0.155 0.095 DBMET00377 0.146 0.117 DBMET02787 | DBMET00377 | |
| 0.005 | 0.439 | 0.021 | Motilin receptor agonist | 0.021 0.019 DBMET02792 | DBMET02792 | |
| 0.066 | 0.511 | 0.242 | Vasodilator, coronary | 0.242 0.142 DBMET02792 | DBMET02792 | |
| 0.027 | 0.473 | 0.083 | NADH dehydrogenase inhibitor | 0.083 0.068 DBMET02792 | DBMET02792 | |
| 0.027 | 0.478 | 0.22 | Amylase inhibitor | 0.22 0.037 DBMET02792 | DBMET02792 | |
| 0.021 | 0.481 | 0.155 | Beta glucuronidase inhibitor | 0.155 0.023 DBMET02792 | DBMET02792 | |
| 0.012 | 0.473 | 0.056 | Antibiotic Aminoglycoside-like | 0.056 0.01 DBMET02792 | DBMET02792 | |
| 0.045 | 0.515 | 0.233 | Angiogenesis inhibitor | 0.233 0.136 DBMET02792 | DBMET02792 | |
| 0.026 | 0.517 | 0.362 | Free radical scavenger | 0.362 0.036 DBMET02792 | DBMET02792 | |
| 0.068 | 0.56 | 0.218 | Caspase 3 stimulant | 0.218 0.144 DBMET02792 | DBMET02792 | |
| 0.032 | 0.523 | 0.144 | DNA methylase inhibitor | 0.144 0.123 DBMET02792 | DBMET02792 | |
| 0.006 | 0.505 | 0.291 | Selectin antagonist | 0.291 0.006 DBMET02792 | DBMET02792 | |
| 0.017 | 0.526 | 0.184 | Lipid peroxidase inhibitor | 0.184 0.048 DBMET02792 | DBMET02792 | |
| 0.005 | 0.519 | 0.043 | Nicotinic acid receptor 2 agonist | 0.043 0.018 DBMET02787 | DBMET02787 | |
| 0.024 | 0.546 | 0.186 | Cell wall synthesis inhibitor | 0.186 0.036 DBMET02792 | DBMET02792 | |
| 0.014 | 0.571 | 0.112 | GABA C receptor agonist | 0.112 0.055 DBMET00377 0.108 0.059 DBMET02787 | DBMET00377 | |
| 0.025 | 0.582 | 0.386 | Antioxidant | 0.386 0.037 DBMET02792 | DBMET02792 | |
| 0.016 | 0.578 | 0.244 | Thrombolytic | 0.244 0.035 DBMET02792 | DBMET02792 | |
| 0.036 | 0.598 | 0.289 | Hepatoprotectant | 0.289 0.033 DBMET02792 | DBMET02792 | |
| 0.023 | 0.596 | 0.263 | DNA synthesis inhibitor | 0.263 0.059 DBMET02792 | DBMET02792 | |
| 0.035 | 0.611 | 0.159 | DNA repair enzyme inhibitor | 0.159 0.024 DBMET02792 | DBMET02792 | |
| 0.015 | 0.6 | 0.288 | Immunostimulant | 0.288 0.082 DBMET02792 | DBMET02792 | |
| 0.03 | 0.621 | 0.185 | Hexokinase inhibitor | 0.185 0.045 DBMET02792 | DBMET02792 | |
| 0.03 | 0.622 | 0.13 | Interferon gamma antagonist | 0.13 0.111 DBMET02792 | DBMET02792 | |
| 0.017 | 0.626 | 0.447 | Angiogenesis stimulant | 0.447 0.016 DBMET02792 | DBMET02792 | |
| 0.028 | 0.645 | 0.082 | Transcription factor NF kappa B stimulant | 0.082 0.066 DBMET02792 | DBMET02792 | |
| 0.068 | 0.726 | 0.315 | Peptidyltransferase inhibitor | 0.315 0.02 DBMET02792 | DBMET02792 | |
| 0.008 | 0.673 | 0.058 | Heparanase inhibitor | 0.058 0.026 DBMET02792 | DBMET02792 | |
| 0.008 | 0.681 | 0.069 | Protein 50S ribosomal subunit inhibitor | 0.069 0.024 DBMET02792 | DBMET02792 | |
| 0.015 | 0.756 | 0.532 | Antibacterial | 0.532 0.033 DBMET02792 | DBMET02792 | |
| 0.05 | 0.821 | 0.332 | Interleukin 2 agonist | 0.332 0.054 DBMET02792 | DBMET02792 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |